Effect of Pemafibrate on Serum Creatinine in Patients with Chronic Kidney Disease

INTRODUCTION: Fibrates are recommended not to be used for the treatment of hypertriglyceridemia in patients with chronic kidney disease (CKD) based on clinical practice guidelines. The major reason for the negative suggestion is the elevation of serum creatinine and rhabdomyolysis by fibrates. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Enyu, Imai, Atsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358292/
https://www.ncbi.nlm.nih.gov/pubmed/35992291
http://dx.doi.org/10.31662/jmaj.2021-0212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358292/
https://www.ncbi.nlm.nih.gov/pubmed/35992291
http://dx.doi.org/10.31662/jmaj.2021-0212

Ejemplares similares